Companies: 10,795·Total market cap: $144.5T
Acutus Medical, Inc.

Acutus Medical, Inc.

AFIBOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$5982
P/E Ratio
52W High$0.014
52W Low$0.0001

Acutus Medical, Inc. (AFIB) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

AFIB · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was −$31.8M for FY2024 (fiscal year ending 2024-12-31), up 49.8% year-over-year The FCF margin was -157.6%.

FY2024 Free Cash Flow−$31.8M▲ +49.8% YoY
Trailing 12M (TTM)−$31.8Mtrailing 4 quarters sum
FCF Margin-157.6%−$31.8M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
afib free cash flow history · afib free cash flow chart · afib free cash flow growth rate · afib free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2024Latest−$31.8M▲ +49.8%-157.6%
FY2023−$63.3M▲ +28.8%-884.1%
FY2022−$89.0M▲ +18.8%
FY2021−$109.7M▼ 13.8%-635.2%
FY2020−$96.4M▼ 38.9%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
afib free cash flow 2024 · afib free cash flow 2023 · afib free cash flow 2022 · afib operating cash flow

FCF valuation metrics

Acutus Medical, Inc. (AFIB) reported negative free cash flow of −$0.03B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31
afib price to free cash flow · afib free cash flow yield · afib free cash flow per share · afib price to cash flow ratio

Cash flow statement summary

For FY2024, Acutus Medical, Inc. generated −$31.7M in operating cash flow and spent 0M in capital expenditures, yielding −$31.8M in free cash flow.

Operating Activities
−$31.7M
Cash from core business operations
2024-12-31
Investing Activities
+$22.1M
CapEx, acquisitions & investments
2024-12-31
Financing Activities
−$2.9M
Buybacks, dividends & debt
2024-12-31
FCF FormulaOperating CF (−$31.7M) − |CapEx| (0M) = FCF (−$31.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
afib cash flow statement · afib cash flow statement 2024 · afib operating cash flow · afib cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Acutus Medical, Inc.
Acutus Medical, Inc.YOU
AFIB
−$31.8M+49.8%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Acutus Medical, Inc. (AFIB) reported free cash flow of −$31.8M for FY2024 (fiscal year ending 2024-12-31), up 49.8% year-over-year. The FCF margin was -157.6%.

Acutus Medical, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 7 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

AFIB free cash flow · 8 questions

Acutus Medical, Inc. free cash flow was −$31.8M for FY2024, up 49.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$31.8M.

AFIB free cash flowAFIB FCFAFIB FCF 2024AFIB free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Acutus Medical, Inc. · Acutus Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026